Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AKTX

Akari Therapeutics Plc ADR

Apr 30 • 11:27AM ET

5.46

+0.22 4.20 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: REGN ALNY NBIX ARGX ADAP FATE CLLS TGTX MCRB VCNX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-19.27	Insider Own	0.40%	Shs Outstand	45.27M	Perf Week	-9.00%
Market Cap	247.17M	Forward P/E	-	EPS next Y	-4.68	Insider Trans	0.00%	Shs Float	45.09M	Perf Month	6.02%
Enterprise Value	242.66M	PEG	-	EPS next Q	-1.33	Inst Own	0.26%	Short Float	0.03%	Perf Quarter	-41.04%
Income	-17.29M	P/S	-	EPS this Y	72.10%	Inst Trans	-	Short Ratio	0.53	Perf Half Y	-82.30%
Sales	0.00M	P/B	8.73	EPS next Y	18.89%	ROA	-35.05%	Short Interest	0.01M	Perf YTD	-52.77%
Book/sh	0.63	P/C	46.99	EPS next 5Y	32.82%	ROE	-68.39%	52W High	59.20 -90.78%	Perf Year	-90.52%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	- -	ROIC	-61.03%	52W Low	3.25 68.00%	Perf 3Y	-96.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.44% 13.55%	Perf 5Y	-99.67%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.85%	Oper. Margin	-	ATR (14)	0.69	Perf 10Y	-99.96%
Dividend Ex-Date	-	Quick Ratio	0.44	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.82	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.44	EPS Q/Q	-	SMA20	10.01%	Beta	0.63	Target Price	33.50
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-20.51%	Rel Volume	3.49	Prev Close	5.24
Employees	6	LT Debt/Eq	0.00	Earnings	Apr 07	SMA200	-73.99%	Avg Volume	27.35K	Price	5.46
IPO	May 07, 2013	Option/Short	No / Yes	EPS/Sales Surpr.	-66.11% -	Trades		Volume	38,230	Change	4.20%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)